Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |